Latest Articles
Circulating biomarkers of infection and endometrial cancer risk - springermedicine.com
Circulating biomarkers of infection and endometrial cancer risk springermedicine.com
Published: Oct. 16, 2025, 2:26 a.m.
Sildenafil in Reproductive Medicine: Promise, Paradox, and the Pursuit of a Receptive Endometrium - viagra8ordernow.com
Sildenafil in Reproductive Medicine: Promise, Paradox, and the Pursuit of a Receptive Endometrium viagra8ordernow.com
Published: Oct. 15, 2025, 9:23 p.m.
SMC Issues Advice on 7 Medicines in Latest Meeting - NAVLIN DAILY
SMC Issues Advice on 7 Medicines in Latest Meeting NAVLIN DAILY
Published: Oct. 14, 2025, 12:08 p.m.
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Oct. 8, 2025, 7:30 p.m.
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III - insights.citeline.com
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III insights.citeline.com
Published: Oct. 8, 2025, 2:15 p.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Vulcan Post
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Vulcan Post
Published: Oct. 8, 2025, 7:33 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Malaysian Reserve
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Malaysian Reserve
Published: Oct. 8, 2025, 2:14 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Fidelity
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Fidelity
Published: Oct. 8, 2025, 1:35 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Manila Times
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Manila Times
Published: Oct. 8, 2025, 1:23 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - PR Newswire
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment PR Newswire
Published: Oct. 8, 2025, 1:08 a.m.
Link copied to clipboard!